General Information
Revision date
2012-08-01
Product name
Adama 2,4-D LV Ester 680 Herbicide
CAS No.
1928-43-4
1.2.1 Relevant identified uses
Agricultural herbicide for use as described on the product label
Icons in SDS
Company Information
company name
Adama Australia Pty Ltd
Section 2
SECTION 2: Hazards identification
Hazard statements
This product is classified as: Xn, Harmful. Xi, Irritating. Hazardous according to the criteria of SWA. Not subject to the ADG Code when transported in Australia by Road or Rail in packages 500kg(L) or less; or IBCs (refer to SP AU01). However if transported by Air or Sea, this provision does not apply. Then the product is classed as Dangerous (Class 9 Environmentally Hazardous) by IATA and IMDG respectively. See details below and in Section 14 of this MSDS. However, this is a C1 Combustible Liquid so must be stored and handled as specified in AS 1940 “The storage and handling of flammable and combustible liquids.” R22, R43. Harmful if swallowed. May cause sensitisation by skin contact
Precautionary statements
S2, S13, S20, S28, S37, S62, S24/25. Keep out of reach of children. Keep away from food, drink and animal feeding stuffs. When using, do not eat or drink. After contact with skin, wash immediately with plenty of soap and water. Wear suitable gloves. If swallowed, do not induce vomiting: seek medical advice immediately and show this MSDS. Avoid contact with skin and eyes.
SUSMP Classification
S6
ADG classification
Class 9 Miscellaneous dangerous goods
UN Number
3082, ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQUID, N.O.S Emergency Overview Physical Description & colour: Clear brown liquid. Odour: Mild odour.
Health hazards
The oral LD50 of 2,4-D ranges from 375 to 666 mg/kg in the rat, 370 mg/kg in mice, and from less than 320 to 1000 mg/kg in guinea pigs. The dermal LD50 values are 1500 mg/kg in rats and 1400 mg/kg in rabbits, respectively. In humans, prolonged breathing of 2,4-D causes coughing, burning, dizziness, and temporary loss of muscle coordination. Other symptoms of poisoning can be fatigue and weakness with possible nausea. On rare occasions following high levels of exposure, there can be inflammation of the nerve endings with muscular effects.
Potential health effects
Inhalation: Short term exposure: Available data indicates that this product is not harmful. However product may be mildly irritating, although unlikely to cause anything more than mild transient discomfort. Long Term exposure: No data for health effects associated with long term inhalation. Skin Contact: Short term exposure: Classified as a potential sensitiser by skin contact. Exposure to a skin sensitiser, once sensitisation has occurred, may manifest itself as skin rash or inflammation, and in some individuals this reaction can be severe. In addition product may be mildly irritating, but is unlikely to cause anything more than mild discomfort which should disappear once contact ceases. Long Term exposure: Prolonged contact with the concentrate can cause defatting of the skin and may result in dermatitis and also absorption of 2,4-D in harmful amounts. Eye Contact: Short term exposure: Available data shows that this product is not harmful. This product may be irritating to eyes, but is unlikely to cause anything more than mild transient discomfort. Long Term exposure: No data for health effects associated with long term eye exposure. Ingestion: Short term exposure: Significant oral exposure is considered to be unlikely. Available data shows that this product is harmful, but symptoms are not available. Ingestion of the product as supplied, in relatively large amounts, can result in headache, nausea, lethargy, motor weakness and incoordination. Long Term exposure: No data for health effects associated with long term ingestion. Carcinogen Status: SWA: No significant ingredient is classified as carcinogenic by SWA. NTP: No significant ingredient is classified as carcinogenic by NTP. IARC: No significant ingredient is classified as carcinogenic by IARC.